Bokf Na Sells $16.6M in Johnson & Johnson Shares

Institutional investor reduces stake in pharmaceutical giant

Mar. 12, 2026 at 8:34am

Got story updates? Submit your updates here. ›

Bokf Na, an institutional investor, lowered its position in shares of Johnson & Johnson (NYSE: JNJ) by 9.0% in the third quarter, according to a recent SEC filing. The firm sold 16,622 shares, reducing its total holdings in the company to 168,123 shares valued at $31,173,000.

Why it matters

Johnson & Johnson is one of the world's largest and most well-known pharmaceutical companies, so changes in institutional ownership of its stock can provide insights into broader market sentiment and investment trends within the healthcare sector.

The details

Bokf Na, a financial services firm based in Oklahoma, sold 16,622 shares of Johnson & Johnson stock during the third quarter. This reduced the firm's total position in JNJ to 168,123 shares, worth approximately $31.2 million. The sale represents a 9.0% decrease in Bokf Na's holdings of the pharmaceutical company's stock.

  • Bokf Na filed its Q3 2026 Form 13F with the SEC on March 12, 2026, disclosing the share sale.

The players

Bokf Na

An institutional investor and financial services firm based in Oklahoma.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Bokf Na's Johnson & Johnson holdings suggests the firm may have a more cautious outlook on the pharmaceutical company's stock performance in the near term, though Johnson & Johnson remains a major player in the healthcare industry.